Allozymes
Temasek-backed Allozymes secures $15m for European expansion
Allozymes’ platform can analyze over 20 million enzyme variants daily.
Temasek’s deeptech arm leads $5m seed round of Singapore biotech startup
Allozymes will use the fresh funds to establish its manufacturing and business infrastructure.
Entrepreneur First names 9 deep-tech startups in seventh Singapore cohort
As part of the program, EF will invest S$75,000 into each of the teams that reach the launch phase in exchange for a 10% stake in each company.
You're up to date! 🙂 Read more articles using our search!

